All industries

Life Sciences

Regulatory Evidence Intelligence

Trial documentation, regulatory submissions, and research records — auditable and certified.

  • Regulatory evidence
  • Trial documentation
  • Expert review networks

Program model

Everything orbits one program — not separate enterprise, partner, and workforce journeys.

  1. 1

    Business objective

    The problem you are solving

  2. 2

    AI Production Program

    Living program at the center

  3. 3

    Certified outcome

    Trust package & deployment

  4. 4

    Business value

    Measurable impact at scale

Starting program

Regulatory Evidence Intelligence

Regulatory Evidence Intelligence

Phase 1 — Discovery

It begins with a business objective

Not a client. Not a partner. Not a platform feature. Every AI Production Program starts with the outcome your organization must deliver.

Business objective

Accelerate regulatory evidence preparation without compromising GxP audit requirements.

That objective becomes your AI Production Program. Partners, workforce, governance, and certification all orbit that single program — nothing restarts when you expand.

Recommended program

Regulatory Evidence Intelligence

We help life sciences organizations produce trusted AI that can:

  • Extract trial and regulatory documents
  • Validate expert review evidence
  • Route senior validator networks
  • Support regulatory affairs teams
  • Govern every submission decision
Production Director

Consulting guidance — not a sales pitch

Production Director speaks from experience with similar organizations in your sector.

Your world

What problems we solve

Life Sciences leaders typically arrive with operational pressure — not a request for annotation or RLHF.

  • 01

    Trial and regulatory documentation volume

  • 02

    Research AI without certification pathways

  • 03

    Expert review bottlenecks

  • 04

    FDA and global regulatory evidence requirements

Phase 10 — Expansion

Program family — typical expansion path

Programs do not complete and disappear. They operate, improve, and expand within the same tenant and engagement.

  1. Phase 1 · Start here

    Regulatory Evidence Intelligence

  2. Phase 2

    Clinical Trial Document Processing

  3. Phase 3

    Research Knowledge AI

  4. Phase 4

    Senior Expert Review Network

Outcomes

Success and governance

What your board and regulators need to see — before and after production.

What success looks like

Research AI is certified with expert validation. Regulatory submissions include defensible evidence. Programs expand across therapeutic areas.

Governance we address

  • FDA and global regulatory requirements
  • Clinical trial data integrity
  • Expert reviewer qualification
  • GxP-compliant audit trails
Behind the membrane

How we deliver

Expertluma orchestrates production behind your program. You see progress, decisions, and outcomes — not factories or task queues.

  • Document intelligence
  • Knowledge systems
  • Expert validation
  • Regulatory certification
Assessment

What your board receives

A consulting-style AI Opportunity Assessment — not software output.

Example engagement

Helix Biosystems — research corpus, senior validator network

Life sciences organizations use Expertluma for governed research AI.

Start assessment — Life Sciences

A consulting engagement to define your AI Production Program. Not a demo request. Not a software trial.